Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathway

Jean-Pierre Rouault, Nicole Falette, Fabienne Guéhenneux, +14

Nature Genetics

Tumor BiologyChromatinGenome InstabilityDna DamageMedicine +9

Expression of a non‐functional p53 affects the sensitivity of cancer cells to gemcitabine

Carlos M. Galmarini, Marilyn L. Clarke, Nicole Falette, +3

International Journal of Cancer

BTG gene expression in the p53-dependent and -independent cellular response to DNA damage

Ulrich Cortes, Caroline Moyret‐Lalle, Nicole Falette, +7

Molecular Carcinogenesis

Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients.

Nicole Falette, Marie-Pierre Paperin, Isabelle Treilleux, +9

PubMed

Tumor BiologyP53 AlterationsBreast OncologyMedicineLarge Series +11

Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics

Carlos M. Galmarini, Kathy Kamath, A Vanier-Viornery, +6

British Journal of Cancer

The human BTG2/TIS21/PC3 gene: genomic structure, transcriptional regulation and evaluation as a candidate tumor suppressor gene

Cyril Duriez, Nicole Falette, Carole Audoynaud, +6

Gene

Tumor BiologyTranscriptional RegulationRadiation OncologyOncogenic AgentMedicine +9

BTG2TIS21/PC3 induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells

Fatiha el-Ghissassi, Sandrine Valsesia‐Wittmann, Nicole Falette, +3

Oncogene

Pc12 CellsCell RegulationApoptosisImmunologyCell Death +6

1,25(OH)2D3 modulation of mammary tumor cell growth in vitro and in vivo

S Saez, Nicole Falette, C�line Guillot, +3

Breast Cancer Research and Treatment

MedicineMammary GlandCell ProliferationBreast CancerRadiation Oncology +6

Estrogen receptor gene methylation in human breast tumors.

Nicole Falette, Suzanne A.W. Fuqua, Gary C. Chamness, +3

PubMed

Tumor BiologyHuman Breast TumorsBreast OncologyEpigenetic ChangeGenetics +11

In vitro study of effects of 1,25 dihydroxyvitamin D3 on the morphology of human breast cancer cell line BT.20

Lucien Frappart, Nicole Falette, Marie France Lefebvre, +3

Differentiation

Breast OncologyMedicinePharmacologyCancer Cell BiologyVitro Study +8